A new research has found that neutrophils—one of the most abundant white blood cells in our body—change drastically in certain cancers, adopting a new function whereby they promote tumor growth. By carefully studying neutrophils as soon as they enter the tumor, scientists also uncovered ways to accurately differentiate tumor-promoting neutrophils from normal neutrophils present in the rest of the body. Neutrophils play important and irreplaceable roles in fighting infections, hence, depletion of neutrophils due to chemotherapy usually leave cancer patients susceptible to potentially fatal infections.
With the ability to specifically single out tumor-promoting neutrophils, this represents a novel way in which tumors can be targeted while preserving the normal neutrophil response. The study was published in Science.
Neutrophils are characterised as the first responders of the immune system, as they migrate rapidly from the blood into tissues to fight off disease-causing pathogens. In cancer, scientists have previously showed that various types of neutrophils present within the tumor play a crucial role in supporting tumor growth, which in turn lead to poorer clinical outcomes in cancer patients. Yet, it was unclear how these different types of neutrophils were generated, and whether they worked in a co-operative fashion to drive tumor progression. Thus, specific targeting of tumor-promoting neutrophils could not be achieved.
To address this, a team of scientists utilised an experimental pre-clinical model of pancreatic cancer, demonstrating that diverse types of neutrophils acquired new characteristics and functions once they migrated into the tumor, a process that was termed “reprogramming”.
Neutrophils that had undergone this reprogramming process would then be unified as a singular population regardless of their initial starting point. Thus, by tracking the reprogramming process, the team could now study how reprogrammed neutrophils ensured the continued growth of the tumor. Reprogrammed neutrophils promoted the growth of new blood vessels within the centre of the tumor, which likely allowed the tumor to overcome the limited access to oxygen and nutrients. When the researchers specifically blocked this vessel-promoting function of reprogrammed neutrophils, or removed them from interacting with the tumor, they were able to reduce the growth of pancreatic tumors in pre-clinical models.
The team also found similar instances of reprogramming when they re-analysed other published data sets in humans, indicating a common pathway where neutrophils can be similarly modified to promote tumor growth in certain solid cancers. As such, this study holds promise for future therapeutic approaches in cancer that target neutrophil reprogramming and their eventual function, synergising with current treatment and immunotherapies that activate the immune system to destroy tumors.
A co-corresponding author on the study, said, “This study leverages the team’s previous work, which identified how diverse neutrophils can be. In this study, we expand on our previous knowledge by uncovering the mechanisms through which tumors induce neutrophils to adopt a tumor-promoting response. This allows us to selectively target reprogrammed neutrophils, which will improve and diversify treatment options for human cancers, while lessening the impact from just targeting neutrophils in a non-specific manner.”
The team plans to further investigate the factors that drive neutrophil reprogramming in human cancers. This is crucial for developing more effective ways to target and treat cancer through strategies focused on neutrophils.
Latest News
Protein that helps COVID-19…
By newseditor
Posted 26 Jul
Spinal Muscular Atrophy (SM…
By newseditor
Posted 26 Jul
Link between bowel movement…
By newseditor
Posted 26 Jul
Inhibition of IL-11 signall…
By newseditor
Posted 25 Jul
Brain changes linked to obe…
By newseditor
Posted 25 Jul
Other Top Stories
'Natural killer' cells could halt Parkinson's progression
Read more
How inflammation triggers fatal cycle in Alzheimer's disease
Read more
A protein controls inflammation through non-enzymatic activities
Read more
Sex-specific traits of the immune system explain men's susceptibili…
Read more
Too much salt weakens the immune system and may increase infections
Read more
Protocols
A systems biology approach…
By newseditor
Posted 24 Jul
quantms: a cloud-based pipe…
By newseditor
Posted 22 Jul
Emerging tools and best pra…
By newseditor
Posted 19 Jul
Directly selecting cell-typ…
By newseditor
Posted 17 Jul
PUFFFIN: an ultra-bright, c…
By newseditor
Posted 16 Jul
Publications
Hepatocyte-intrinsic SMN de…
By newseditor
Posted 26 Jul
Aberrant bowel movement fre…
By newseditor
Posted 26 Jul
A pseudoautosomal glycosyla…
By newseditor
Posted 26 Jul
Microglia protect against a…
By newseditor
Posted 26 Jul
Rigor and reproducibility i…
By newseditor
Posted 26 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar